Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Electromyography and Kinesiology : Official Journal of the International Society of Electrophysiological Kinesiology|October 15, 2019
The needle EMG findings in myotonia congenitaMonika Nojszewska, Anna Lusakowska, Malgorzata Gawel, et al.
Neurologia I Neurochirurgia Polska|July 6, 2022
Value of short exercise and short exercise with cooling tests in diagnosis of recessive form of myotonia congenita (Becker disease) - are sex differences important?Monika Nojszewska, Anna Lusakowska, Malgorzata Gawel, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 1, 2013
Recurrent K3E mutation in Cu/Zn superoxide dismutase gene associated with amyotrophic lateral sclerosisMagdalena Kuźma-Kozakiewicz, Mariusz Berdyński, Mitsuya Morita, et al.
Neurologia I Neurochirurgia Polska|March 29, 2018
Evidence for a relatively high proportion of DM2 mutations in a large group of Polish patientsAnna Sulek, Anna Lusakowska, Wioletta Krysa, et al.
Neurologia I Neurochirurgia Polska|June 9, 2018
WITHDRAWN: Evidence for a relatively high proportion of DM2 mutations in a large group of Polish patientsAnna Sulek, Anna Lusakowska, Wioletta Krysa, et al.
Muscle & Nerve|December 22, 2016
Abnormal spontaneous activity in primary myopathic disordersMonika Nojszewska, Malgorzata Gawel, Elzbieta Szmidt-Salkowska, et al.
Muscle & Nerve|June 8, 2017
Effects of repeated abobotulinumtoxinA injections in upper limb spasticityJean-Michel Gracies, Michael O'Dell, Michele Vecchio, et al.
Neurology. Clinical Practice|October 5, 2019
Consensus-based care recommendations for adults with myotonic dystrophy type 2Benedikt Schoser, Federica Montagnese, Guillaume Bassez, et al.
Human Molecular Genetics|June 23, 2017
Identification of exosomal muscle-specific miRNAs in serum of myotonic dystrophy patients relating to muscle disease progressAndrie Koutsoulidou, Marinos Photiades, Tassos C Kyriakides, et al.
Neuromuscular Disorders : NMD|November 28, 2020
Long-term follow-up of patients with type 2 and non-ambulant type 3 spinal muscular atrophy (SMA) treated with olesoxime in the OLEOS trialFrancesco Muntoni, Enrico Bertini, Giacomo Comi, et al.
Pageof 4